LIN.US

457.62

+0.78%↑

SHW

363.11

+0.48%↑

SCCO

90.65

-1.78%↓

ECL

258.96

+1.22%↑

APD

278.72

+1.63%↑

LIN.US

457.62

+0.78%↑

SHW

363.11

+0.48%↑

SCCO

90.65

-1.78%↓

ECL

258.96

+1.22%↑

APD

278.72

+1.63%↑

LIN.US

457.62

+0.78%↑

SHW

363.11

+0.48%↑

SCCO

90.65

-1.78%↓

ECL

258.96

+1.22%↑

APD

278.72

+1.63%↑

LIN.US

457.62

+0.78%↑

SHW

363.11

+0.48%↑

SCCO

90.65

-1.78%↓

ECL

258.96

+1.22%↑

APD

278.72

+1.63%↑

LIN.US

457.62

+0.78%↑

SHW

363.11

+0.48%↑

SCCO

90.65

-1.78%↓

ECL

258.96

+1.22%↑

APD

278.72

+1.63%↑

Avantor Inc

Затворен

СекторБазови материали

13.39 4.28

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

12.59

Максимум

13.41

Ключови измерители

By Trading Economics

Приходи

-440M

60M

Продажби

-105M

1.6B

P/E

Средно за сектора

12.5

54.64

EPS

0.23

Марж на печалбата

3.819

Служители

13,500

EBITDA

-491M

239M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+34.79% upside

Дивиденти

By Dow Jones

Следващи печалби

25.07.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.4B

8.9B

Предишно отваряне

9.11

Предишно затваряне

13.39

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Avantor Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

25.04.2025 г., 13:52 ч. UTC

Печалби
Значими двигатели на пазара

Avantor Shares Fall on Cut Guidance, Lower Demand

25.04.2025 г., 11:02 ч. UTC

Печалби

Avantor Cuts Outlook as Policy Shifts Dent Demand in Certain Markets

Сравнение с други в отрасъла

Ценова промяна

Avantor Inc Прогноза

Ценова цел

By TipRanks

34.79% нагоре

12-месечна прогноза

Среден 17.32 USD  34.79%

Висок 24 USD

Нисък 14 USD

Според 16 анализатори от Wall Street, предложили 12-месечна ценова цел за Avantor Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

16 ratings

9

Купи

7

Задържане

0

Продай

Техническа оценка

By Trading Central

11.965 / 12.57Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Weak Bearish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Avantor Inc

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.